Cooperations
The Medical Physics and Radiotherapy group collaborates with world-leading institutions in cancer therapy to further improve proton therapy and patient safety.
Cooperation partners
The vision of the Dresden Center ZIK OncoRay is to decisively improve the cure of cancer through biologically individualized, technologically optimal radiotherapy. The focus and strategy of OncoRay address the great need for preclinical and clinical translational research in this field. OncoRay is affiliated with the Proton and Photon Therapy of the University Hospital Dresden. The center, which started operations in 2005, is jointly supported by the Technical University of Dresden, the Helmholtz Center Dresden - Rossendorf and the University Hospital Carl Gustav Carus.
The WPE has four therapy rooms with various proton radiation techniques and the possibility of image guidance by X-ray, CT and MRI. Currently, the WPE treats in particular non-moving tumors in the head, spine and pelvis (i.e., primarily primary brain tumors as well as sarcomas of the skull base, facial skull, spine and pelvis). Prostate and nasopharyngeal carcinomas are also treated, as well as, since 2019, the first moving tumors in the breast and liver. The treatment of children is currently a major focus at WPE.
The HIT offers cancer treatment with heavy ion and proton therapy. At the HIT, selected cancers are irradiated in adults, as well as children and adolescents. Tumor irradiation while sparing the surrounding healthy tissue is especially important for tumor sites being close to sensitive tissues and organs, such as the base of skull, optic nerve, or intestine, as well as tumors in children and adolescents.